Fetal trisomy 21 and maternal preeclampsia

Epidemiology

Volumn 15, Issue 2, 2004, Pages 195-201

  Zhang, Jun ^a,c   Christianson, Roberta E ^b   Torfs, Claudine P ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PUBLIC HEALTH INSTITUTE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL FREE SYSTEM; CIRCULATION; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS CELL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTIPARA; NULLIPARA; OUTCOMES RESEARCH; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TRISOMY 21; TROPHOBLAST; UNITED STATES; EDUCATIONAL STATUS; FACTUAL DATABASE; HYPERTENSION; MALE; NEWBORN; PARITY; PREGNANCY; PRENATAL CARE; SMOKING;

ADULT; CALIFORNIA; DATABASES, FACTUAL; DOWN SYNDROME; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERTENSION; INFANT, NEWBORN; MALE; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; SMOKING; UNITED STATES;

EID: 2442444231     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000112141.09008.37     Document Type: Article

References (28)

1. Knight M, Redman CWG, Linton EA, et al. Shedding of syncytiotrophoblast microvilli into maternal circulation in preeclamptic pregnancies. Br J Obstet Gynecol 1998;105:632-640.
2. Smarason AK, Sargent IL, Starkey PM, et al. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynecol. 1993;100:943-949.
3. Cockell AP, Learmont JG, Smarason AK, et al. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial cell function. Br J Obstet Gynecol. 1997;104:235-240.
4. Lo YMD, Leung TN, Tein MSC, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999;45:184-188.
5. Zhong XY, Laivuori H, Livingston JC, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184:414-419.
6. Leung TN, Zhang J, Lau TK, et al. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem. 2001;47:137-139.
7. Lo YMD, Lau TK, Zhang J, et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem. 1999;45:1747-1751.
8. Zhong XY, Burk MR, Troeger C, et al. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn. 2000;20:795-798.
9. Bianchi DW, Williams JM, Sulllivan LM, et al. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet. 1997;61:822-829.
10. Brizot ML, Jauniaux E, Mckie AT, et al. Placental expression of alpha and beta subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome. Hum Reprod. 1995;10:2506-2509.
11. Dalgliesh GL, Aithen DA, Lyall F, et al. Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies. Placenta. 2001;22:227-234.
12. Sorensen TK, Williams MA, Zingheim RW, et al. Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol. 1993;169:834-838.
13. Muttukrishna S, North RA, Morris J, et al. Serum inhibin A and activin A are elevated prior to the onset of preeclampsia. Hum Reprod. 2000;15:1640-1645.
14. Taffel SM, Ventura SJ, Gay GA. Revised US certificate of birth: new opportunities for research on birth outcome. Birth. 1989;16:188-193.
15. Torfs CP, Christianson RE. Effect of maternal smoking and coffee consumption on the risk of having a recognized Down syndrome pregnancy. Am J Epidemlol. 2000;152:1185-1191.
16. Lindheimer MD, Roberts JM, Cunningham FG. Chesley's Hypertensive Disorders in Pregnancy, 2nd ed. Stamford, CT: Appleton & Lange; 1999.
17. Cuckle H. Down syndrome fetal loss rate in early pregnancy. Prenat Diagn. 1999;19:1175-1180.
18. Qureshi F, Jacques SM, Johnson MP, et al. Trisomy 21 placentas: histopathological and immunohistochemical findings using proliferating cell nuclear antigen. Fetal Diagn Ther. 1997;12:210-215.
19. Jauniaux E, Hustin J. Chromosomally abnormal early ongoing pregnancies: correlation of ultrasound and placental histological findings. Hum Pathol. 1998;29:1195-1199.
20. Rochelson B, Kaplan C, Guzman E, et al. A quantitative analysis of placental vasculature in the third-trimester fetus with autosomal trisomy. Obstet Gynecol. 1990;75:59-63.
21. Frendo JL, Vidaud M, Guibourdenche J, et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down syndrome. J Clin Endocrinol Metab. 2000;85:3700-3707.
22. Roberts JM. Endothelial dysfunction in preeclampsia. Sem Reprod Endocrinol. 1998;16:5-15.
23. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation and disease. Arch Biochem Biophys. 2001;389:84-93.
24. Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia. Placenta. 2001;22:206-212.
25. Frendo JL, Therond P, Bird T, et al. Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation. Endocrinology. 2001;142:3638-3648.
26. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol. 1998;16:93-104.
27. Cunningham FG, Gant NF, Leveno KJ, et al. Williams Obstetrics, 21st ed. New York: McGraw-Hill; 2001:572.
28. Zhang J, Meikle S, Trumble A. Preeclampsia-eclampsia associated severe maternal morbidity in the United States. Hypertens Pregnancy. 2003;22:203-212.